Tang B, Liu C, Shen L, Dai H, Pan Q, Jing L, Ouyang S, Xia J
Department of Neurology, Xiangya Hospital, Hunan Medical University, People's Republic of China.
Arch Neurol. 2000 Apr;57(4):540-4. doi: 10.1001/archneur.57.4.540.
To assess the frequency of SCA1 (spinocerebellar ataxia type 1), SCA2, SCA3/MJD (spinocerebellar ataxia type 3/Machado-Joseph disease), SCA6, SCA7, and DRPLA (dentatorubropallidoluysian atrophy) CAG trinucleotide repeat expansions [(CAG)n] among persons diagnosed with hereditary SCA from Chinese families.
Spinocerebellar ataxia type 1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA (CAG)n mutation were detected with the polymerase chain reaction, highly denaturing polyacrylamide gel electrophoresis, and silver staining technique in 167 patients with autosomal dominant SCA from 85 Chinese families and 37 patients with sporadic SCA.
Spinocerebellar ataxia type 1 (CAG)n mutation in 7 patients from 4 kindreds (4.70%) was expanded to 53 to 62 repeats. Spinocerebellar ataxia type 2 (CAG)n mutation in 12 patients from 5 kindreds (5.88%) was expanded to 42 to 47 repeats. Spinocerebellar ataxia type 3/Machado-Joseph disease (CAG)n mutation in 83 patients from 41 kindreds (48.23%) was expanded to 68 to 83 repeats. Sixty-five patients from 35 kindreds (41.19%) and 37 patients with sporadic SCA did not test positive for SCA1, SCA2, SCA3/MJD, SCA6, SCA7, or DRPLA. There was a predictable inverse relationship between the number of CAG repeats and the age at onset for SCA3/MJD and SCA2. Clinically, dementia and hyporeflexia were more frequent in patients with SCA2, while spasticity, hyperreflexia, and Babinski signs were more frequent in patients with SCA3/ MJD, and those might be helpful in clinical work to primarily distinguish patients with SCA3/MJD and SCA2 from others with different types of SCA.
The frequency of SCA3/MJD is substantially higher than that of SCA1 and SCA2 in patients with autosomal dominant SCA from Chinese kindreds, who are non-Portuguese. Clinical expressions of the various types of SCAs overlap one another; therefore, for clinical study it is important to make a gene diagnosis and genetic classification for patients with SCA.
评估在中国家族中被诊断为遗传性脊髓小脑共济失调(SCA)的人群中,脊髓小脑共济失调1型(SCA1)、SCA2、SCA3/马查多-约瑟夫病(MJD,即脊髓小脑共济失调3型)、SCA6、SCA7和齿状核红核苍白球路易体萎缩症(DRPLA)的CAG三核苷酸重复扩增[(CAG)n]的发生频率。
采用聚合酶链反应、高度变性聚丙烯酰胺凝胶电泳及银染技术,对来自85个中国家族的167例常染色体显性遗传性SCA患者及37例散发性SCA患者进行SCA1、SCA2、SCA3/MJD、SCA6、SCA7和DRPLA的(CAG)n突变检测。
4个家系的7例患者(4.70%)存在SCA1的(CAG)n突变,重复次数扩增至53至62次。5个家系的12例患者(5.88%)存在SCA2的(CAG)n突变,重复次数扩增至42至47次。41个家系的83例患者(48.23%)存在SCA3/马查多-约瑟夫病的(CAG)n突变,重复次数扩增至68至83次。35个家系的65例患者(41.19%)以及37例散发性SCA患者的SCA1、SCA2、SCA3/MJD以及SCA6、SCA7或DRPLA检测未呈阳性。对于SCA3/MJD和SCA2,CAG重复次数与发病年龄之间存在可预测的负相关关系。临床上,SCA2患者中痴呆和反射减退更为常见,而SCA3/MJD患者中痉挛、反射亢进和巴宾斯基征更为常见,这些表现可能有助于临床工作中初步将SCA3/MJD和SCA2患者与其他类型SCA患者区分开来。
在非葡萄牙裔的中国家系常染色体显性遗传性SCA患者中,SCA3/MJD的发生频率显著高于SCA1和SCA2。不同类型SCA的临床表型相互重叠;因此,对于SCA患者进行基因诊断和基因分型在临床研究中很重要。